Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Ford’s Legal Legacy: Both Friend and Foe By most accounts, President Gerald R. Ford’s legal legacy was one of the high points of his 896 days in office. Taking over the White House in the wake of the Watergate scandal, his attempt to end the “national nightmare” was, at its core, a legal matter. • Relief Pitcher: Safavian Turns to New Lawyer For Appeal David Safavian, the one-time top procurement official at the Office of Management and Budget, has turned to Lawrence Robbins of Robbins, Russell, Englert, Orseck & Untereiner. • Buh-Bye: Wallace Withdraws From 5th Circuit Consideration Michael Wallace, the Mississippi lawyer nominated for a seat on the U.S. Court of Appeals for the 5th Circuit, says he’s not waiting around any longer for the job. • Sprung: Bush Reduces Sentence in Drug Case The White House clearly believes if you do the crime, you do the time. President George W. Bush has only granted three reductions in sentencing in six years in office, making Phillip Emmert’s commutation a rare executive Christmas gift. • Village Victory: Foster Children Protected in Civil-Rights Suit Four Native American villages in Alaska won a preliminary victory from the Alaska Supreme Court in their civil-rights suit seeking to end alleged violations of federal laws that protect Native American foster children from being removed from their communities. • False Start: Suspension Recommended for Attorney Falsifying His R�sum� The D.C. Bar’s Board on Professional Responsibility recommended a 30-day suspension for attorney Gregory Hawn on Dec. 5 for allegedly padding his r�sum�. • Clubbed: D.C. Club Fighting Array of Suits The George Town Club, a members-only dining establishment on Wisconsin Avenue that bills itself as “one of the most elegant in-town clubs in the United States,” is in the midst of fighting off an array of discrimination, harassment, and wrongful-termination complaints filed by three longtime employees. • Drug Benefit: Patent Upheld in Schizophrenia Drug Case Finnegan, Henderson, Farabow, Garrett & Dunner scored a major victory for its client Eli Lilly & Co. last week, when a federal appeals court upheld the company’s patent on Zyprexa, a leading schizophrenia drug and the company’s top seller. • Pay Me My Money: More Attorneys Could Head to Federal Court for Better Income The low rate of pay and recent changes in the payment-voucher system for court-appointed attorneys at the D.C. Court of Appeals may cause more experienced lawyers to leave for more lucrative work at the federal courthouse across the street.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.